2014 Financial Results
Most contract service providers that publicly report financial results had done so by the end of March 2015. In our March issue of Bio/Pharmaceutical Outsourcing Report, we review the summary results for the key service sectors: API, finished dose form (FDF), clinical research and lab services. The table below provides the details for the companies included in that article.
- Catalent results are for 12 months ended 12/31/2014. Company fiscal year is 6/30.
- Famar is private, but reported revenues on website.
- SGS Life Sciences includes clinical CRO revenues, but they are not broken out from lab services.